Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs

Question 861: Which of the following is not a commonly reported adverse effect of imatinib?

A. Myalgia
B. Periorbital edema
C. Hepatotoxicity (Correct Answer)
D. Pleural effusion

Explanation: ***Hepatotoxicity*** - **Hepatotoxicity IS a commonly reported adverse effect** of imatinib, occurring in approximately **10-15% of patients** with elevated liver enzymes. - However, compared to the **extremely high frequency** of fluid retention manifestations (occurring in 50-70% of patients), hepatotoxicity is **relatively less characteristic** of imatinib's adverse effect profile. - **Regular liver function monitoring** is required during imatinib therapy, and the FDA labeling includes hepatotoxicity warnings. - Among the listed options, this represents the **least predictable** adverse effect compared to the nearly universal fluid retention issues. *Periorbital edema* - **Fluid retention** with **periorbital edema** is the **most characteristic and common** adverse effect of imatinib, occurring in **60-70% of patients**. - This is due to imatinib's effect on **PDGF and c-KIT receptors** affecting vascular permeability and interstitial fluid regulation. - Often one of the first adverse effects patients notice. *Myalgia* - **Muscle aches and cramps** occur in **40-50% of patients** taking imatinib. - Often managed with **magnesium supplementation**, hydration, and dose adjustment. - Represents a very commonly reported musculoskeletal adverse effect. *Pleural effusion* - Part of the **fluid retention spectrum** associated with imatinib therapy. - Occurs in **5-10% of patients**, particularly with higher doses or in elderly patients. - May require dose reduction, diuretics, or temporary drug discontinuation in severe cases.

Question 862: Which of the following is an adverse effect of methysergide?

A. Metabolic syndrome
B. Endocardial fibrosis (Correct Answer)
C. Peyronie's syndrome
D. Dry mouth

Explanation: ***Endocardial fibrosis*** - Methysergide is known to cause **retroperitoneal, pleuropulmonary, and endocardial fibrosis** due to its serotonergic action. - This adverse effect can lead to **restrictive cardiomyopathy** and valvular heart disease if treatment is prolonged. *Metabolic syndrome* - Metabolic syndrome is characterized by a cluster of conditions such as **increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels**. - It is often associated with antipsychotics and other medications, but not a primary adverse effect of methysergide. *Peyronie's syndrome* - **Peyronie's disease** involves the development of **fibrous scar tissue** inside the penis, causing curved, painful erections. - While it involves fibrosis, it is not a recognized adverse effect of methysergide. *Dry mouth* - Dry mouth, or **xerostomia**, is a common side effect of many medications, particularly those with anticholinergic properties. - While some medications can cause dry mouth, it is not a characteristic or significant adverse effect associated with methysergide, which is known for its fibrotic complications.

Question 863: Which drug is used to prolong the action of local anesthetics in hypertensive patients?

A. Clonidine
B. Felypressin (Correct Answer)
C. Dexmedetomidine
D. Noradrenaline

Explanation: ***Felypressin*** - Felypressin is a **vasoconstrictor** that prolongs the action of local anesthetics by reducing their systemic absorption without causing significant **alpha-adrenergic stimulation**, making it a safer option for hypertensive patients. - It acts as a **vasopressin V1 receptor agonist**, leading to vasoconstriction primarily in the splanchnic and skeletal muscle beds, with less impact on cardiac function compared to adrenergic vasoconstrictors. *Clonidine* - Clonidine is an **alpha-2 adrenergic agonist** used as an adjuvant to local anesthetics, primarily for its **sedative** and **analgesic** properties, and to some extent for prolongation of block. - While it can prolong local anesthetic action, its primary use is not as a direct vasoconstrictor to reduce systemic absorption, and it can cause **hypotension** and **bradycardia**, which might complicate care in some hypertensive patients. *Dexmedetomidine* - Dexmedetomidine is a highly selective **alpha-2 adrenergic agonist** used for its **sedative** and **analgesic** effects, and as an adjunct to local anesthetics to prolong their duration. - Similar to clonidine, its primary role is not as a direct vasoconstrictor to minimize systemic absorption, and it carries the risk of **hypotension** and **bradycardia**, making it less ideal solely for vasoconstriction in hypertensive patients. *Noradrenaline* - Noradrenaline (norepinephrine) is a potent **alpha-1 adrenergic agonist** that causes intense vasoconstriction, which would significantly prolong the action of local anesthetics. - However, its strong vasoconstrictive effects and potential for **systemic arterial hypertension** and tachycardia make it generally contraindicated or used with extreme caution in hypertensive patients due to the risk of exacerbating their condition.

Question 864: Local anaesthetic causing methemoglobinemia is ?

A. Dibucaine
B. Chloroprocaine
C. Procaine
D. Benzocaine (Correct Answer)

Explanation: ***Benzocaine*** - **Benzocaine** is a common cause of **methemoglobinemia**, particularly with topical application or excessive doses. - It converts **ferrous iron (Fe2+)** in hemoglobin to **ferric iron (Fe3+)**, leading to impaired oxygen binding and delivery. *Dibucaine* - **Dibucaine** is an amide-type local anesthetic with a long duration of action. - While it can cause systemic toxicity, it is **not commonly associated** with methemoglobinemia. *Chloroprocaine* - **Chloroprocaine** is an ester-type local anesthetic known for its rapid hydrolysis by plasma cholinesterases. - Its short half-life and rapid metabolism make **methemoglobinemia an unlikely side effect**. *Procaine* - **Procaine** is another ester-type local anesthetic, the first synthetic local anesthetic. - While all ester-type local anesthetics have a theoretical risk, **procaine is rarely implicated** in causing clinically significant methemoglobinemia compared to benzocaine.

Question 865: What is the percentage of tetracaine commonly used in cataract surgery?

A. 0.5% (Correct Answer)
B. 1%
C. 2%
D. 4%

Explanation: ***0.5%*** - A **0.5% concentration** of tetracaine is commonly used as a **topical anesthetic** in cataract surgery. - This concentration provides sufficient surface anesthesia for procedures without causing excessive corneal toxicity. *1%* - While 1% tetracaine can be used, it is generally considered a **higher concentration** than typically needed for routine cataract surgery. - Higher concentrations may increase the risk of **corneal epithelial toxicity** and delayed wound healing. *2%* - A 2% concentration of tetracaine is **rarely used** for topical anesthesia in cataract surgery due to its significantly increased risk of **corneal toxicity** and damage. - Such high concentrations are typically reserved for more intense, short-duration anesthetic needs, not routine ophthalmic procedures. *4%* - A 4% concentration of tetracaine is **not typically used** as a topical anesthetic for cataract surgery due to the very high risk of **significant corneal damage** and adverse effects. - This concentration would be **excessively potent** and harmful to the delicate ocular surface.

Question 866: Which is a safe muscle relaxant in renal failure?

A. Cisatracurium (Correct Answer)
B. Vecuronium
C. Succinylcholine
D. Rocuronium

Explanation: ***Cisatracurium*** - It is eliminated by **Hofmann elimination**, a non-enzymatic chemical degradation process that does not rely on renal or hepatic function. - Its metabolism generates **laudanosine**, which is minimally active and primarily excreted by the kidneys, but its impact is negligible in typical dosing. *Rocuronium* - Primarily eliminated by the **liver**, with a small percentage excreted renally. - In renal failure, its **duration of action can be prolonged** due to decreased excretion and potential accumulation of metabolites. *Vecuronium* - Undergoes **hepatic metabolism** to active metabolites, which are then excreted renally. - In patients with renal dysfunction, the **active metabolites can accumulate**, significantly prolonging its neuromuscular blockade. *Succinylcholine* - Metabolized by **plasma pseudocholinesterase**, an enzyme not significantly affected by renal failure. - However, in renal failure patients with **hyperkalemia**, succinylcholine use is contraindicated due to its potential to further increase serum potassium, leading to dangerous arrhythmias.

Question 867: Clinical alarming sign of MgSO4 toxicity is?

A. Loss of knee jerk (Correct Answer)
B. Loss of superficial abdominal reflexes
C. Loss of pin prick sensation
D. Loss of proprioception

Explanation: ***Loss of knee jerk*** - **Magnesium sulfate (MgSO4)** toxicity manifests as central nervous system and neuromuscular depression. - The **knee jerk reflex** (patellar reflex) is one of the first deep tendon reflexes to be lost as magnesium levels approach toxic ranges, typically at serum levels of 7-10 mg/dL. *Loss of superficial abdominal reflexes* - Superficial reflexes are less sensitive indicators of impending **MgSO4 toxicity** compared to deep tendon reflexes. - While magnesium can cause muscle relaxation, the loss of these reflexes is not the primary or earliest clinical alarming sign. *Loss of pin prick sensation* - **Pinprick sensation** tests sensory pathways and is not directly affected by the neuromuscular blocking effects of magnesium sulfate. - Magnesium toxicity primarily affects motor function and deep tendon reflexes, not sensory perception. *Loss of proprioception* - **Proprioception** is the sense of joint position and movement, which is also a sensory function. - Magnesium toxicity does not typically cause a direct loss of proprioception; its effects are predominantly on motor nerve conduction and muscle contraction.

Question 868: What are the common side effects of the influenza vaccine?

A. Fever after vaccination
B. Itching at the injection site
C. Local swelling at the injection site
D. All of the options (Correct Answer)

Explanation: ***All of the options*** - The influenza vaccine commonly causes both **local and systemic side effects** as part of the body's normal immune response to vaccination. - All three listed side effects are well-documented common reactions that typically resolve within 1-2 days. **Local Reactions at Injection Site:** - **Soreness, pain, redness, and swelling** occur in 10-64% of vaccine recipients, representing the most common adverse effects. - **Itching** at the injection site is also frequently reported as part of the local inflammatory response. - These reactions indicate the immune system is responding appropriately to the vaccine antigens. **Systemic Reactions:** - **Fever** occurs in 10-40% of recipients (more common in children than adults), usually mild and lasting 1-2 days. - May be accompanied by other systemic symptoms like **myalgia, headache, and malaise**. - These represent the body's systemic immune response to the vaccine. **Clinical Significance:** - All these side effects are **expected, mild, and self-limiting** reactions. - They do not indicate vaccine failure or serious adverse events. - Patients should be counseled that these reactions are normal and typically resolve without intervention.

Question 869: Which of the following statements about MgSO4 is false?

A. Not used as antihypertensive (Correct Answer)
B. It acts as a membrane stabilizer and neuroprotector
C. Deep tendon reflexes are monitored for toxicity
D. Duration of therapy may differ between eclampsia and preeclampsia

Explanation: ***Not used as antihypertensive*** - This statement is **false** because **Magnesium sulfate (MgSO4)** is indeed used for its **antihypertensive** properties, especially in obstetric emergencies like **preeclampsia** and **eclampsia**, where it helps lower blood pressure. - While its primary role in these conditions is seizure prevention, its **vasodilatory effects** contribute to blood pressure reduction. *Deep tendon reflexes are monitored for toxicity* - This statement is **true**. The primary sign of impending **Magnesium sulfate toxicity** is the **loss of deep tendon reflexes**, particularly the patellar reflex. - Monitoring reflexes is crucial for safe administration and to prevent serious complications like **respiratory depression**. *It acts as a membrane stabilizer and neuroprotector* - This statement is **true**. MgSO4 is thought to exert its **anticonvulsant** effect by acting as a **membrane stabilizer** and a **neuroprotector**. - It reduces neuronal excitability, blocks glutamate receptors, and antagonizes calcium influx, thereby protecting brain cells from damage. *Duration of therapy may differ between eclampsia and preeclampsia* - This statement is **true**. The **loading dose** (4-6g IV) and **maintenance dose** (1-2g/hr) of MgSO4 are typically the same for both conditions. - However, the **duration of therapy** differs based on clinical presentation: eclampsia treatment requires continuation for 24 hours after the last seizure, while preeclampsia may require shorter durations. - Eclampsia may also necessitate longer monitoring to prevent recurrent seizures.

Question 870: Which of the following vaccines is most likely to cause adverse effects in individuals with egg allergies?

A. Meningococcal vaccine
B. Influenza vaccine (Correct Answer)
C. Hepatitis B vaccine
D. Pneumococcal vaccine

Explanation: ***Influenza vaccine*** - Historically and currently, **most influenza vaccines are manufactured using embryonated chicken eggs**, which introduces egg proteins into the vaccine - While modern influenza vaccines contain **very small amounts of ovalbumin** (egg protein), they remain the vaccine **most likely to cause concerns** in individuals with egg allergies among the options listed - Current CDC and ACIP guidelines state that individuals with egg allergy can receive influenza vaccine without special precautions, but it is still the vaccine with **historical egg allergy associations** - Some egg-free recombinant and cell-based influenza vaccines are now available for those with severe egg allergies *Hepatitis B vaccine* - The **Hepatitis B vaccine is produced using recombinant DNA technology** in yeast cells (Saccharomyces cerevisiae) - It contains **no egg proteins whatsoever** and is completely safe for individuals with egg allergies - There is no biological basis for egg allergy concerns with this vaccine *Pneumococcal vaccine* - Both **pneumococcal polysaccharide (PPSV23) and conjugate (PCV13/PCV15/PCV20) vaccines** are manufactured using bacterial culture systems - They contain **no egg proteins** and pose no risk to individuals with egg allergies - Safe for all egg-allergic individuals without any precautions *Meningococcal vaccine* - **Meningococcal vaccines** (both conjugate and polysaccharide forms) are produced using bacterial components - Manufacturing process **does not involve eggs or egg products** - Completely safe for individuals with egg allergies

Practice by Chapter

Principles of Clinical Pharmacology

Practice Questions

Therapeutic Drug Monitoring

Practice Questions

Drug Toxicity and Overdose

Practice Questions

Antidotes and Their Applications

Practice Questions

Management of Drug Poisoning

Practice Questions

Drug-Induced Liver Injury

Practice Questions

Drug-Induced Kidney Injury

Practice Questions

Drug-Induced Blood Dyscrasias

Practice Questions

Drug-Induced QT Prolongation

Practice Questions

Pharmacovigilance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free